The largest database of trusted experimental protocols

Pma ionomycin mixture

Manufactured by MultiSciences Biotech
Sourced in China

PMA/ionomycin mixture is a laboratory reagent used to stimulate cells and induce cellular responses. It contains phorbol 12-myristate 13-acetate (PMA) and ionomycin, which work synergistically to activate various signaling pathways within the cell.

Automatically generated - may contain errors

3 protocols using pma ionomycin mixture

1

Jurkat T Cell Activation Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Jurkat T cell was obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China) and cultured in 1640 medium supplemented with 10% fetal bovine serum (FBS, Gibco, Australia) and 1% penicillin-streptomycin in an incubator with humidified 5% CO2 at 37 °C. The plasmids pCDNA3.1, pCMV-NFATC1 and pCMV-NFATC1-S617 were synthesized by Genechem (Shanghai, China) and then the transfection was performed according to the manufacturer’s protocol. Detailed information of plasmids construction was presented in the Table S1. The cells were stimulated by PMA/Ionomycin mixture (Multi Sciences, Hangzhou, China) for 24 h among Stimulated group, pCDNA3.1 group, pCMV-NFATC1 group and pCMV-NFATC1-S617 group. The naive Jurkat T cell was defined as Control group.
+ Open protocol
+ Expand
2

Immune Cell Characterization in Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions of tumor-infiltrated immune cells were prepared. Cells were incubated with anti-CD16/CD32 antibody (BD Pharmingen, #553141) to minimize non-specific binding. All cell surface reactions (CD45, CD3, CD4, CD8, CD25, CD206, I-A/I-E, CD11c, CD11b, F4/80, PD-1, CD86, Ly-6G, and Ly-6C) were performed at 4 ℃ for 30 min. Activated human primary T cells (Stemcell Technologies) were treated for 24 h and 4 h, respectively, with a PMA/ionomycin mixture (MultiSciences, Hangzhou, China, #70-CS1001) and brefeldin A (BFA) (Sigma-Aldrich, MO, USA, #B5936) as pretreatment. The T cells were fixed and permeabilized using the Fixation/Permeabilization Set protocol (eBioscience, CA, USA, #00-5123-43, #00-5223-56, #00-8333-56) and incubated with IFN-γ antibody (BD Pharmingen, #554700) in the dark for 30 min. The permeabilization step allowing intracellular staining (KI-67, IFN-γ, GZMB, and Foxp3) was performed referring to the manufacturer’s protocol (BD Pharmingen, #562574, #550583). The gating strategy is shown in Additional file 3: Fig. S3. All the tumors in each group were detected. In addition, when using flow cytometry to measure the abundance of PD-L1 expression on the surface of pancreatic cancer cells, each group examined three independent samples.
+ Open protocol
+ Expand
3

Identification and Analysis of B10 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorescent mAbs CD4, CD19, CD11c, F4/80, CD1d, CD5 and IL-10 were purchased from Elabscience (Wuhan, China). Intracellular staining was conducted as described previously (Yang et al., 2012 (link)). Splenocytes from mice were suspended in the presence of PMA/ionomycin mixture (Phorbol 12-myristate 13-acetate, Multisciences) and monensin (Multisciences) for 5 hours to analyze B10 cells (CD1dhiCD5+B19+IL-10+). Then, the cells were collected and stained with PE Anti-CD19 mAbs, FITC anti-CD1d mAbs and PerCP/Cyanine5.5 anti-CD5 mAbs. After removing the unbound antibodies, the cells were fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences, San Jose, CA). Then, they were stained with APC mouse anti-IL-10 following the manufacturer’s instructions. The samples were performed using BD FACSCanto flow cytometer (BD Biosciences), and the results were analyzed using FlowJo Software (Version X; TreeStar, Ashland, OR).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!